12.03
0.04 (0.33%)
| Previous Close | 11.99 |
| Volume | 44,833 |
| Price / Sales | 1.54 |
| Price / Book | 0.650 |
| 52 Weeks Range |
| Profit Margin | -41.07% |
| Operating Margin (TTM) | -39.88% |
| Diluted EPS (TTM) | -4.40 |
| Quarterly Revenue Growth (YOY) | -25.70% |
| Total Debt/Equity (MRQ) | 2.18% |
| Current Ratio (MRQ) | 3.53 |
| Operating Cash Flow (TTM) | -30.88 M |
| Levered Free Cash Flow (TTM) | 9.06 M |
| Return on Assets (TTM) | -5.06% |
| Return on Equity (TTM) | -17.25% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - General (US) | Mixed | Bullish |
| Drug Manufacturers - General (Global) | Mixed | Bullish | |
| Stock | Amarin Corporation plc | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -0.67 |
Select this tab to load the latest available analysis.
|
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| % Held by Insiders | 1.88% |
| % Held by Institutions | 17.94% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Waterfront Wealth Inc. | 30 Jun 2026 | 213,949 |
| Lcm Capital Management Inc | 30 Jun 2026 | 51,362 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |